Page results
-
UCLH works in partnership with GPs in Barnet and Enfield to provide a community based ear, nose and throat (ENT) service. The Community ENT service provides specialist advice and treatment for a range of minor ENT conditions.
-
A UCLH patient with a rare hormonal condition is the first in the world to receive a new investigational drug in a first-in-human trial.
-
This page provides information on transperineal biopsies of the prostate.
-
As an organisation, UCLH needs to minimise the environmental impact of our buildings and the energy they use and maximise our use of any technology available to support these changes. This page outlines our progress to date.
-
Find & Treat's new prototype Eco-Tricycle will visit parks, hostels, soup kitchens, be able to arrive under bridges or other street outreach locations to screen homeless patients for infectious diseases and more.
-
UCLH today marks International Clinical Trials Day, which this year coincides with the National Institute for Health Research (NIHR) campaign encouraging everyone to ‘Be Part of Research.’
-
The pancreatobiliary department at UCLH is one of few centres in the UK to provide a patient-centred, comprehensive advanced interventional endoscopy service for diseases of the pancreas and biliary tree.
-
A surgical operation normally carried out to correct a blocked nasal passage may help patients who lost their sense of smell after contracting a COVID-19 infection, according to new research from UCLH.
-
This page has been written for patients who wish to find out more about a new procedure for epilepsy that does not involve removing parts of brain, known as EASEE® (Epicranial Application of Stimulation Electrodes for Epilepsy)
-
Our thoracic/respiratory medicine service offers a comprehensive inpatient and outpatient medical service for adults with conditions affecting the lungs.
File results
-
FOI/2023/0296 - Consultant workforce information
-
FOI/2023/0300 - Post-mortem examinations for 2019, 2020, 2021 and 2022
-
FOI/2023/0301 - Meat served at the Trust that may contain nitrates or nitrites
-
FOI/2023/0303 - Sexual harassment from patients towards staff in 2022
-
FOI/2023/0304 - Chronic lymphocytic leukaemia treatments
-
FOI/2023/0308 - Treatment for biologic and biosimilar products within rheumatology
-
FOI/2023/0310 - Biologic treatment/ medicines in dermatology
-
FOI/2023/0313 - Consent, confidentiality and information sharing in mental healthcare and suicide
-
FOI/2023/0315 - Menopause Lead at the Trust
-
FOI/2023/0319 - Multiple Sclerosis (MS) treatment/ medication for any diseases